 BEIJING--BUSINESS WIRE--Genetron Holdings Limited Genetron Health or the Company, Nasdaq: GTH, a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that management will present at the BTIG Early Cancer Screening, Diagnostics Reimbursement and Genomic Tools KOL Day on Jan. 22, 2021. Yunfu Hu, PhD, Chief Medical Officer of Genetron Health, is sch 